CLINICAL RESEARCH: BIOMARKER
Heart-Type Fatty Acid-Binding Protein Predicts Long-Term Mortality After Acute Coronary Syndrome and Identifies High-Risk Patients Across the Range of Troponin Values
Niamh Kilcullen, MRCPI*,2,*,
Karthik Viswanathan, MRCP*,3,
Rajiv Das, MRCP*,2,
Christine Morrell*,
Amanda Farrin, MSc ,
Julian H. Barth, MD, FRCP, FRCPath ,1,
Alistair S. Hall, PhD, FRCP*,1 for the EMMACE-2 Investigators
* Coronary Artery Disease Clinical Research Network Group, Leeds Institute for Genetic, Health & Therapeutics, Leeds, United Kingdom
Clinical Trials Research Unit, University of Leeds, Leeds, United Kingdom
Department of Clinical Biochemistry, General Infirmary at Leeds, Leeds, United Kingdom.
Manuscript received November 6, 2006;
revised manuscript received July 23, 2007,
accepted August 21, 2007.
* Reprint requests and correspondence: Dr. Niamh Kilcullen, C-NET Group, Clinical Cardiology, G Floor Jubilee Building, General Infirmary at Leeds, Leeds, LS1 3EX Yorkshire, United Kingdom. (Email: niamhkilcullen{at}doctors.org.uk).
Objectives: Our aim was to determine if a high-performance assay for heart-type fatty acid-binding protein (H-FABP) has a role in predicting all-cause mortality after acute coronary syndrome (ACS).
Background: Heart-type fatty acid-binding protein is released into the circulation following myocardial ischemia and necrosis and therefore may be of value to physicians when caring for patients admitted to hospital with a clinical diagnosis of ACS.
Methods: This was a prospective observational study with a follow-up of 12 months. The H-FABP was measured 12 to 24 h after onset of symptoms in 1,448 patients admitted to hospital with ACS. The main outcome measure was all-cause mortality 1 year after index hospital admission. Multivariable analyses were conducted using the well validated GRACE (Global Registry of Acute Coronary Events) variables together with troponin I and highly sensitive C-reactive protein (hs-CRP).
Results: After 12 months of follow-up, 296 patients had died. Multivariable analysis demonstrated that H-FABP quartiles were strongly predictive of outcome: Q1 hazard ratio (HR) 1.0; Q2 HR 2.32 (95% confidence interval [CI] 1.25 to 4.30; p = 0.007); Q3 HR 3.17 (95% CI 1.73 to 5.82; p < 0.001); Q4 HR 4.88 (95% CI 2.67 to 8.93; p < 0.001). The crude all-cause 1-year mortality for unstable angina patients with H-FABP <5.8 µg/l was 2.1% compared with 22.9% for patients above this cutoff. The adjusted all-cause mortality HR in this group was 11.35 (95% CI 2.00 to 64.34; p = 0.006).
Conclusions: Heart-type fatty acid-binding protein predicts long-term mortality after ACS and identifies high-risk patients in a manner that is additive to the GRACE clinical risk factors, troponin, and hs-CRP, possibly as a result of identifying the occurrence of myocardial ischemia with or without necrosis.
|
Abbreviations and Acronyms
| | ACS = acute coronary syndrome | | CV = coefficient of variation | | ECG = electrocardiogram | | H-FABP = heart-type fatty acid-binding protein | | hs-CRP = highly sensitive C-reactive protein | | MI = myocardial infarction | | TnI = troponin I |
|
Related Article
-
The Skinny on Fatty Acid-Binding Protein
- James A. de Lemos and Michelle O’Donoghue
J. Am. Coll. Cardiol. 2007 50: 2068-2070.
[Full Text]
[PDF]
This article has been cited by other articles:
|
|
|
|
 
S. E. Orfanos and S. Zakynthinos
Heart biomarkers as prognostic tools for chronic thromboembolic pulmonary hypertension: a step forward by the fatty acid-binding protein
Eur. Respir. J.,
May 1, 2008;
31(5):
915 - 917.
[Full Text]
[PDF]
|
|
|
|
|
|
|
A. N. DeMaria, J. J. Bax, O. Ben-Yehuda, P. Clopton, G. K. Feld, G. S. Ginsburg, B. H. Greenberg, J. D. Knoke, W. Y.W. Lew, J. A.C. Lima, et al.
Highlights of the year in JACC 2007.
J. Am. Coll. Cardiol.,
January 29, 2008;
51(4):
490 - 512.
[Full Text]
[PDF]
|
|
|
|
|
|
|
J. A. de Lemos and M. O'Donoghue
The Skinny on Fatty Acid-Binding Protein
J. Am. Coll. Cardiol.,
November 20, 2007;
50(21):
2068 - 2070.
[Full Text]
[PDF]
|
|
|
|
